PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1238836
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1238836
Leukapheresis Market size was valued at USD 130.8 million in 2022, expanding at a CAGR of 8.7% from 2023 to 2030.
One of the processes used in apheresis is leukapheresis. With increased research and development efforts in their product portfolio, it is anticipated that leukapheresis demand will increase considerably. During a leukapheresis process, white blood cells, including leukaemia cells, are removed and the remaining blood cells are reintroduced into the bloodstream. The leukapheresis procedure is expected to develop more rapidly in the upcoming years due to the rising incidence of leukaemia.
Some of the key aspects dominating the industry are anticipated to fuel the global leukapheresis market. These reasons include the growing leukoplakia demand as well as the increase in blood donations. The increasing demand for leukoplakias in the creation of cell-based therapies is another factor driving the growth of the leukapheresis market. Additionally, there has been a substantial increase in the incidence of leukaemia cancer over the past few years, which is predicted to drive the global leukapheresis market. During the anticipated era, it is predicted that the prevalence of diseases and the increasing number of trauma cases will promote the growth of the leukapheresis market.
In addition, the possibilities and benefits of leukapheresis in this application make it a market focus, especially given that very few hospital in both developed and emerging markets currently provide leukapheresis treatment for children. However, the high cost of leukapheresis procedures and a dearth of qualified doctors are expected to impede the market's growth in the coming years. Nonetheless, rising government investments and increased competition among key players are expected to provide enormous growth opportunities to market participants in the coming years.
The Global Leukapheresis Market is segmented based on type, application, end-use, and Region.
The global market is divided into leukapheresis devices and leukapheresis disposables based on their type. The leukapheresis device market segment had the highest market share globally. The market expansion of this segment was being driven by the rising use of therapeutic leukapheresis methods and equipment for the treatment of leukaemia. Another important factor promoting industry growth is the rising adoption of blood collection centres using these devices. Additionally, the market is expanding as a result of the increasing number of product releases and mergers & acquisitions by market participants. For instance, the JCRC business developed an apheresis device that aids in cell collection and is being used in nations like Uganda in May 2019. The device makes use of advancements in the industry and optical detection technology, which improves the segment's development prospects.
North America is expected to have a large market share in the leukapheresis market due to the region's growing geriatric population and rising prevalence and incidence of leukaemia. The North American Association of Central Cancer Registries (NAACCR) predicts that in 2022, 60,650 individuals will receive a leukaemia diagnosis. The Terry Fox Research Institute estimates that 21,700 individuals in Canada received blood cancer diagnoses in 2019. People of all ages are affected by these cancers, and the form of blood cancer can have a significant impact on survival rates. According to estimates, blood malignancies claim the lives of 7,500 Canadians annually, ranking third among all cancer-related fatalities. Thus, the aforementioned facts support the market growth in the region.
In July 2021, a direct offering for doctors to conduct extracorporeal photopheresis immunotherapy (ECP) procedures at the patient's bedside was announced by Terumo Blood and Cell Technologies. The capabilities of Spectra Optia have been increased by the business. These tools enable the fully closed, online, multistep UVA PIT System ECP with mononuclear cell collection (MNC) and continuous mononuclear cell collection (CMNC) protocols.
This proposed research study on the Leukapheresis market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Leukapheresis market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Leukapheresis market
Impact of COVID-19 on Leukapheresis market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Leukapheresis market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Leukapheresis market, we have also included competitive landscape and key innovator analysis for the Leukapheresis market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Leukapheresis market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Leukapheresis market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows: